PharmaMar Signs a Commercialization and Distribution License Agreement for Aplidin(R) (plitidepsin) With Megapharm in Israel

MADRID, January 2, 2018 -- (Healthcare Sales & Marketing Network) --PharmaMar (MCE: PHM) has announced today a commercialization and distribution license agreement with Megapharm Ltd. for the marine-derived anticancer drug Aplidin® (plitidepsin) in Is... Biopharmaceuticals, Oncology, Licensing, Distribution PharmaMar , Megapharm, Aplidin, plitidepsin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news